Stock VENUSREM VENUS REMEDIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Venus Remedies Limited NSE India S.E.

Equities

VENUSREM

INE411B01019

Market Closed - NSE India S.E.
Other stock markets
 07:43:53 2024-05-28 am EDT 		5-day change 1st Jan Change
297.3 INR +0.05% Intraday chart for Venus Remedies Limited -2.52% -26.82%
Mar. 19 Venus Remedies Secures Marketing Authorizations in Ukraine for Three Oncology Drugs MT
Mar. 08 Venus Remedies Gets Ukraine's Marketing Approval for Three Oncology Products MT

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Venus Remedies Secures Marketing Authorizations in Ukraine for Three Oncology Drugs
MT
Venus Remedies Gets Ukraine's Marketing Approval for Three Oncology Products
MT
Venus Remedies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Venus Remedies Gets Ukraine Marketing Approval for Chemotherapy Drug, Antibiotics
MT
Venus Remedies Gets Marketing Authorization in Malta for Two Chemotherapy Drugs
MT
Venus Remedies Gets Authorization to Market Cancer Drugs in Israel, Colombia
MT
Venus Remedies Expands Into Wellness Business
MT
Venus Remedies Gets Bahrain Marketing Authorization for Enoxaparin
MT
Venus Remedies Gets Azerbaijan's Marketing Approval for Blood Clot Prevention Drug
MT
Venus Remedies Gets Marketing Approval for Cancer Drugs in Philippines, Saudi Arabia
MT
Venus Remedies Limited Receives Market Authorizations in Saudi Arabia and Philippines
CI
Venus Remedies' Consolidated Profit Jumps in Fiscal Q2
MT
Venus Remedies Arm Gets Authorization to Market Cancer Drug in UK
MT
Venus Remedies Secures Marketing Approval for Six Key Chemotherapy Drugs in Philippines
MT
Venus Remedies Limited Receives Marketing Approval from the Philippines for Six Key Chemotherapy Drugs
CI
Venus Remedies Launches Antibiotic Elores in Ecuador
MT
Venus Remedies Limited Expands Global Reach with the Launch of Elores in Ecuador
CI
Venus Remedies Gets Marketing Authorization from Serbia for Chemotherapy Drugs
MT
Venus Remedies Limited Extends Its Oncology Portfolio in South Eastern Europe with Serbian Marketing Approval for Gemcitabine and Docetaxel
CI
Venus Remedies Gets Saudi Arabia Marketing Approval for Enoxaparin
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VENUSREM Stock
  4. VENUSREM Stock
  5. News Venus Remedies Limited
  6. Highlights